Healthtech Series A Investors & VC Firms
2309 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
PACE Healthcare Capital
ChicagoSeed–Series B$1M – $4M
18 people
Revo Capital
IstanbulSeed–Series A$250K – $5M
9 people
Consonance Investment Managers
EbeneSeed–Growth
8 people
Indico Capital Partners
LisbonSeed–Growth$250K – $10M
11 people
IW Capital
LondonSeed–Growth
17 people
Oncology Ventures
New YorkSeed–Series A
17 people
Roo Capital
New YorkPre-Seed–Series A$500K – $25M
14 people
Refinery Venture
CincinnatiSeed–Series A$1M – $2M
12 people
Deviation Capital
New YorkSeed–Series A
16 people
Medical Excellence Capital
New YorkSeed–Series B
19 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$2M – $10M
10 people
Serpentine Ventures
ZürichSeed–Growth
7 people
Amino Collective
BerlinPre-Seed–Series A$216K – $1.6M
8 people
Allumia Ventures
SeattleSeries A–Series C$5M – $15M
12 people
Sciety
StockholmSeed–Growth
21 people
Catalytic Impact Foundation
HinghamPre-Seed–Series A
8 people
Sabadell Venture Capital
BarcelonaSeed–Series A$216K – $2.2M
8 people
Yabeo
PullachSeed–Series B
14 people
Green Pine Capital Partners
ShenzhenPre-Seed–Series B
2 people
big_bets
Pre-Seed–Series A$300K – $2M
6 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
16 people
aws Gründungsfonds
ViennaPre-Seed–Growth$108K – $1.6M
13 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
Delos Capital
CambridgeSeed–Growth
13 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Healthtech Investors & VC Firms (4190)Series A Investors & VC Firms in United States (3838)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Healthtech Investors & VC Firms in United States (2436)Series A Investors & VC Firms in Europe (2383)
Data sourced from public filings and firms' own websites — see our methodology.










































































































